Análise da demanda de judicialização de medicações e insumos para saúde no Estado da Paraíba

• Autor(a) principal: Ribeiro, Vanessa Meira Cintra
• Data de Publicação: 2017
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UNISANTOS
• Texto Completo: https://tede.unisantos.br/handle/tede/4001
• topic: assistência farmacêutica; economia da saúde; judicialização em saúde; pharmaceutical assistance; health economics; judicialization in health; case study; CIENCIAS DA SAUDE::SAUDE COLETIVA

Introduction: The structure of Pharmaceutical Care (FC), based on the National Medicines Policy and the National Pharmaceutical Assistance Program, is organized to guarantee a broad spectrum of drug assistance to prevalent pathologies. However, even with this AF structure and organization profile, there has been an increase in the number of users who resort to health judicializations, requesting inputs or specific drugs often not covered by SUS. Objective: To analyze the judicialization of health related to the Pharmaceutical Assistance of the State of Paraíba, through the lawsuit lawsuits for the purchase of medicines under the responsibility of the State Health Department (SES / PB) of 2013. Methods: Cross-sectional study , Quantitative data from the lawsuits for the acquisition of medicine and health supplies of 2013. The database of the Health Economics Center (NES / PB) and financial database of the Pharmaceutical Assistance Center (NAF) were used. Descriptive and inference statistical analyzes (p> 0.05) performed in the R® program. A coroplast map was drawn from the TabWin® program. The research was approved by the Research Ethics Committee of the Catholic University of Santos (CAAE: 64520316.0.0000.5536). Results: 3510 cases were requested with 4339 medications, with an average of 1.2 (± 0.68) per requesting user, which processed in 47 varas of the state, being the majority of João Pessoa and Campina Grande, representing 92% . Profile of the population: 59.6% were female, 48.9% were elderly. There was a higher proportion in the group of elderly patients who used continuous medication, 73.5% (p <0.001). With regard to the diseases that led to the judicialization, it was observed that 40.7% were endocrine diseases, respiratory diseases, neoplasms and the circulatory system, especially diabetes whose proportion was 26.2%. The IJ (Judicialization index) of Paraíba was 0.9 judgments for every 10,000 inhabitants. There was an association between IJ and HDI variables (municipality, longevity, income and schooling), total population and demographic density by municipality, illiteracy rate and percentage of extremely poor population by means of the Kendall test and bivariate linear regression, both With p <0.05. It was observed in a multiple regression analysis (p <0.001) that the population (¿ = 1,950) and the HDI of the municipality (¿ = 3.701) interfered positively in IJ growth. Regarding the economic aspects, it was observed that: the judicialization accounted for 4.2% of the state's own health expenditure, 44.8% with oncology, and the per capita expenditure was R $ 10548.79 (40 times more than The state's per capita health investment), 372 types of drugs were purchased, of which 12 had a price variation of> 90%. Increase in judicialization in the biennium 2012/2013 in number (512) and financial impact (50.95%). Conclusion: The study verified the increase in the judicialization in the state of Paraíba, following a national trend, associated to social factors related to population development, reinforcing the need for stimulus in the articulation between the judiciary and health sector with a view to optimizing access to medicines. This is reinforced by the importance of epidemiological studies and the identification of weaknesses in favor of management and SUS.